The OxyLo Team        

Our Story

OxyLo is a San Diego based Biotechnology company. We focus on helping liver patients get their life back. Our patent pending HypoxyCaps are a revolutionary biomaterial-based implant designed to actively remove oxygen and glucose from the inside of a tumor. Our mission is to starve these tumors to give hope and time back to patients who need it most.

We are a team of international PhD scientists with a combined 40 years of experience working in biology, chemistry, and engineering. Our philosophy of focusing on creativity and interdisciplinary science has led to the breakthrough innovations that we aim to provide today.

Core management team

Scientific Advisory Board

Isabel Newton, M.D., Ph.D. Interventional Radiologist

Tom Molley, PhD Chief Executive Officer
& Co-founder

Rebekah white, MD, FACS Surgical Oncologist

Kristopher Kilian, PhD Chief Scientific Advisor
& Co-founder

James Mackay, PhD

CEO of Kateran Consulting

Erin LaMontagne, PhD VP of Research & Development

Mike Damore, PhD

CEO of Damore TransMed Consulting

Mike Hoerres, MS

CEO at Aquinas Life Sciences

Let’s Work Together